2 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 2 |
Follow Primary Hypercholesterolemia or Mixed Hyperlipidemia: new trials by email Literature Review of Primary Hypercholesterolemia or Mixed Hyperlipidemia trials Research Report on Primary Hypercholesterolemia or Mixed Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia QLC7401, Placebo - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 510 | 2026-03-05 | 2026-03-02 |
| QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) QLC7401, Placebo - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 780 | 2026-03-01 | 2026-03-04 |
Hyperlipoproteinemia Type II (2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyslipidemias (2) · Genetic Diseases, Inborn (2) · Hyperlipidemias (2) · Hyperlipoproteinemias (2) · Lipid Metabolism Disorders (2) · Lipid Metabolism, Inborn Errors (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2)